217 related articles for article (PubMed ID: 7046899)
21. Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma.
Johnson GJ; Costello WG; Oken MM; Sponzo RW; Barnes JM; Ezdinli EZ; Bennett JM; Silverstein MN; Glick JH; Berard CW
Cancer; 1983 Oct; 52(7):1133-41. PubMed ID: 6192894
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy (CVP or CHOP)- radiotherapy approach in early stage non-Hodgkins's lymphomas.
Comella P; Scoppa G; Abate G; Comella G; Apice G; Castello G; Pergola M; Giordano GG; Coucourde F; Zarrilli D
Tumori; 1982 Apr; 68(2):137-42. PubMed ID: 6896940
[TBL] [Abstract][Full Text] [Related]
24. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant chemotherapy for localized non-Hodgkin's lymphoma with CVP therapy].
Horikoshi N; Inagaki J; Ogawa M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1878-84. PubMed ID: 6683953
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma.
Johnson RE; Canellos GP; Young RC; Chabner BA; DeVita VT
Cancer Treat Rep; 1978 Mar; 62(3):321-5. PubMed ID: 580598
[TBL] [Abstract][Full Text] [Related]
27. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
28. Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
Bajetta E; Valagussa P; Bonadonna G; Lattuada A; Buzzoni R; Rilke F; Banfi A
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):3-12. PubMed ID: 2455701
[TBL] [Abstract][Full Text] [Related]
29. CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma.
Jackson DV; Muss HB; Richards F; White DR; Spurr CL; Cooper MR; Christian RM; Trahey TF; Case LD; Wells HB
Cancer Chemother Pharmacol; 1983; 11(3):191-5. PubMed ID: 6357517
[TBL] [Abstract][Full Text] [Related]
30. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
31. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in non-Hodgkin's lymphoma.
Tubiana M; Carde P; Burgers JM; Cosset JM; Van Glabbeke M; Somers R
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):503-14. PubMed ID: 3516950
[TBL] [Abstract][Full Text] [Related]
33. Combination versus successive single agent chemotherapy in lymphocytic lymphoma.
Kennedy BJ; Bloomfield CD; Kiang DT; Vosika G; Peterson BA; Theologides A
Cancer; 1978 Jan; 41(1):23-8. PubMed ID: 580070
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphomas-present status of chemotherapy.
Young CW
Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
[No Abstract] [Full Text] [Related]
35. [Clinical aspects and therapy of anaplastic T-zone lymphoma].
Bartels H; Schneider B; Feller AC
Dtsch Med Wochenschr; 1984 Jul; 109(28-29):1112-6. PubMed ID: 6204832
[TBL] [Abstract][Full Text] [Related]
36. Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.
Abate G; Comella P; Di Pietro N; Ganzina F; Pergola M; Silvestro P; Basso A; Salvatore M; Zarrilli D
Tumori; 1987 Feb; 73(1):43-7. PubMed ID: 3469805
[TBL] [Abstract][Full Text] [Related]
37. [Contribution of anthracyclines in treatment of lymphoproliferative disorders].
Coiffier B
Pathol Biol (Paris); 1987 Jan; 35(1):75-8. PubMed ID: 2436132
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas.
Karakas T; Bergmann L; Stutte HJ; Jäger E; Knuth A; Weidmann E; Mitrou PS; Hoelzer D
Leuk Lymphoma; 1996 Dec; 24(1-2):121-9. PubMed ID: 9049968
[TBL] [Abstract][Full Text] [Related]
39. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
40. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Cabanillas F; Burgess MA; Bodey GP; Freireich EJ
Am J Med; 1983 Mar; 74(3):382-8. PubMed ID: 6187213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
